Biotherapeutic agents - A neglected modality for the treatment and prevention of selected intestinal and vaginal infections

被引:255
作者
Elmer, GW [1 ]
Surawicz, CM [1 ]
McFarland, LV [1 ]
机构
[1] UNIV WASHINGTON,DIV GASTROENTEROL,DEPT MED,SCH MED,SEATTLE,WA 98195
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1996年 / 275卷 / 11期
关键词
D O I
10.1001/jama.275.11.870
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective.-To evaluate the potential of biotherapeutic agents (microorganisms with therapeutic properties) for the prevention and/or treatment of selected intestinal and vaginal infections. Data Sources.-The MEDLINE database was searched for all relevant articles published between 1966 and September 1995. Search terms used were biotherapeutic agent, probiotic, Lactobacillus, Saccharomyces, Bifidobacterium, Candida, gastrointestinal-system, vaginitis, vaginosis-bacterial, and related terms. The bibliographies of obtained articles were also reviewed. Study Selection and Data Extraction.-All placebo-controlled human studies on biotherapeutic agents were reviewed, English-language open trials, case series and reports, and animal studies were reviewed only if they were especially relevant to providing information on the potential efficacy, adverse effects, or mechanisms of action of these agents. Data Synthesis.-Placebo-controlled studies have shown that biotherapeutic agents have been used successfully to prevent antibiotic-associated diarrhea (Lactobacillus casei GG, Bifidobacterium longum, B longum with L acidophilus, and Saccharomyces boulardii), to prevent acute infantile diarrhea (Bifidobacterium bifidum with Streptococcus thermophilus), to treat recurrent Clostridium difficile disease (S bouiardii), and to treat various other diarrheal illnesses (Enterococcus faecium SF68, L casei GG, and S boulardii), There is also limited evidence for Lactobacillus acidophilus in the prevention of candidal vaginitis, Few adverse effects have been reported, However, many of the studies tested only small numbers of patients or volunteers. Conclusions.-There is now evidence that administration of selected microorganisms is beneficial in the prevention and treatment of certain intestinal and, possibly, treatment of vaginal infections. In an effort to decrease the reliance on antimicrobials, the time has come to carefully explore the therapeutic applications of biotherapeutic agents.
引用
收藏
页码:870 / 876
页数:7
相关论文
共 81 条
  • [1] [Anonymous], FORTSCHR MED
  • [2] [Anonymous], 1977, Gazette Medicale de France
  • [3] Axelsson L., 1989, MICROB ECOL HEALTH D, V2, P131, DOI [DOI 10.3109/08910608909140210, 10.3109/08910608909140210]
  • [4] ANTIBIOTIC-ASSOCIATED DIARRHEA
    BARTLETT, JG
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 15 (04) : 573 - 581
  • [5] ASSOCIATION OF GASTRIC HYPOACIDITY WITH OPPORTUNISTIC ENTERIC INFECTIONS IN PATIENTS WITH AIDS
    BELITSOS, PC
    GREENSON, JK
    YARDLEY, JH
    SISLER, JR
    BARTLETT, JG
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (02) : 277 - 284
  • [6] LACTOBACILLUS-ACIDOPHILUS LA-1 BINDS TO CULTURED HUMAN INTESTINAL-CELL LINES AND INHIBITS CELL ATTACHMENT AND CELL INVASION BY ENTEROVIRULENT BACTERIA
    BERNET, MF
    BRASSART, D
    NEESER, JR
    SERVIN, AL
    [J]. GUT, 1994, 35 (04) : 483 - 489
  • [7] TREATMENT OF RECURRENT CLOSTRIDIUM-DIFFICILE COLITIS WITH LACTOBACILLUS GG
    BILLER, JA
    KATZ, AJ
    FLORES, AF
    BUIE, TM
    GORBACH, SL
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1995, 21 (02) : 224 - 226
  • [8] BLATZ R, 1987, MICROECOL T, V17, P191
  • [9] DISPOSITION KINETICS OF SACCHAROMYCES-BOULARDII IN MAN AND RAT
    BLEHAUT, H
    MASSOT, J
    ELMER, GW
    LEVY, RH
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1989, 10 (04) : 353 - 364
  • [10] INHIBITION OF ADHESION OF ESCHERICHIA-COLI K88 TO PIGLET ILEAL MUCUS BY LACTOBACILLUS SPP
    BLOMBERG, L
    HENRIKSSON, A
    CONWAY, PL
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1993, 59 (01) : 34 - 39